MedPath

NYU LANGONE HEALTH

NYU LANGONE HEALTH logo
🇺🇸United States
Ownership
Private
Established
1841-01-01
Employees
10K
Market Cap
-
Website
http://www.nyulangone.org

Tranexamic Acid (TXA) Versus Epsilon Aminocaproic Acid (EACA) Versus Placebo for Spine Surgery

Phase 4
Completed
Conditions
Scoliosis
Interventions
First Posted Date
2009-08-13
Last Posted Date
2018-01-17
Lead Sponsor
NYU Langone Health
Target Recruit Count
177
Registration Number
NCT00958581
Locations
🇺🇸

New York University School of Medicine - Department of Orthopaedic Surgery - Spine, New York, New York, United States

Psilocybin Cancer Anxiety Study

Early Phase 1
Completed
Conditions
Cancer
Interventions
First Posted Date
2009-08-12
Last Posted Date
2020-10-20
Lead Sponsor
NYU Langone Health
Target Recruit Count
29
Registration Number
NCT00957359
Locations
🇺🇸

NYU College of Dentistry Bluestone Center for Clinical Research, New York, New York, United States

Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility

Not Applicable
Completed
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
First Posted Date
2009-08-06
Last Posted Date
2016-03-28
Lead Sponsor
NYU Langone Health
Target Recruit Count
18
Registration Number
NCT00953862

A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients

Phase 4
Completed
Conditions
Brain Tumor
Epilepsy
Hypertension
Interventions
First Posted Date
2009-08-04
Last Posted Date
2015-02-09
Lead Sponsor
NYU Langone Health
Target Recruit Count
22
Registration Number
NCT00952081
Locations
🇺🇸

NYU Langone Medical Center, Department of Anesthesiology, New York, New York, United States

Efficacy of IV Palo With IV Dexamethasone vs IV Palo for Prevention of Immediate & Delayed PONV

Phase 4
Completed
Conditions
PONV
Interventions
First Posted Date
2009-08-04
Last Posted Date
2015-04-17
Lead Sponsor
NYU Langone Health
Target Recruit Count
118
Registration Number
NCT00952133
Locations
🇺🇸

NYU Langone Medical Center, New York, New York, United States

Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors

Phase 1
Completed
Conditions
Tumors, Central Nervous System
Interventions
Biological: Montanide
First Posted Date
2009-07-09
Last Posted Date
2016-01-26
Lead Sponsor
NYU Langone Health
Target Recruit Count
15
Registration Number
NCT00935545
Locations
🇺🇸

NYU Langone Medical Center, New York, New York, United States

Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease

Phase 4
Completed
Conditions
Alzheimer's Disease
Interventions
Drug: Placebo
First Posted Date
2009-07-07
Last Posted Date
2014-10-21
Lead Sponsor
NYU Langone Health
Target Recruit Count
17
Registration Number
NCT00933608
Locations
🇺🇸

NYU School of Medicine, Dept. of Psychiatry, Center for Brain Health, New York, New York, United States

Adolescent Daughters' Response and Adjustment to Maternal Breast Cancer

Terminated
Conditions
Breast Cancer
First Posted Date
2009-07-07
Last Posted Date
2016-06-24
Lead Sponsor
NYU Langone Health
Target Recruit Count
43
Registration Number
NCT00933088
Locations
🇺🇸

Bellevue Hospital Center, New York, New York, United States

🇺🇸

New York University Cancer Center, New York, New York, United States

Non Invasive Biomarkers to Identify Subjects at Risk for Preterm Delivery

Terminated
Conditions
Preterm Birth
First Posted Date
2009-06-12
Last Posted Date
2020-05-13
Lead Sponsor
NYU Langone Health
Target Recruit Count
32
Registration Number
NCT00919412
Locations
🇺🇸

Winthrop-University Hospital, Mineola, New York, United States

Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests

Completed
Conditions
Ischemic Heart Disease
First Posted Date
2009-05-25
Last Posted Date
2011-11-30
Lead Sponsor
NYU Langone Health
Target Recruit Count
200
Registration Number
NCT00907855
Locations
🇺🇸

Nuclear Cardiology/Stress Lab, NYU Cardiology Division, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath